Perdagangan CVS Health - CVS CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.16 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.030779% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.013666% | ||||||||
Waktu biaya inap | 22:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
CVS Health Corp ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Key Stats
Prev. Close* | 85.18 |
Open* | 84.84 |
1-Year Change* | -22.27% |
Day's Range* | 84.84 - 86.41 |
52 wk Range | 84.82-111.25 |
Average Volume (10 days) | 10.08M |
Average Volume (3 months) | 147.94M |
Market Cap | 112.02B |
P/E Ratio | 36.23 |
Shares Outstanding | 1.31B |
Revenue | 315.23B |
EPS | 2.35 |
Dividend (Yield %) | 2.83871 |
Beta | 0.62 |
Next Earnings Date | Feb 8, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 85.93 | 0.91 | 1.07% | 85.02 | 86.56 | 84.44 |
Feb 6, 2023 | 85.18 | -0.18 | -0.21% | 85.36 | 86.51 | 85.10 |
Feb 3, 2023 | 85.70 | -0.79 | -0.91% | 86.49 | 87.52 | 85.52 |
Feb 2, 2023 | 86.07 | -0.02 | -0.02% | 86.09 | 86.91 | 85.35 |
Feb 1, 2023 | 87.36 | -0.55 | -0.63% | 87.91 | 88.10 | 86.53 |
Jan 31, 2023 | 88.09 | 1.24 | 1.43% | 86.85 | 88.41 | 86.85 |
Jan 30, 2023 | 86.98 | -0.82 | -0.93% | 87.80 | 88.29 | 86.91 |
Jan 27, 2023 | 87.68 | 0.03 | 0.03% | 87.65 | 88.04 | 86.92 |
Jan 26, 2023 | 87.55 | 1.18 | 1.37% | 86.37 | 87.69 | 85.95 |
Jan 25, 2023 | 85.68 | 0.63 | 0.74% | 85.05 | 85.94 | 84.75 |
Jan 24, 2023 | 85.95 | -0.47 | -0.54% | 86.42 | 86.91 | 85.84 |
Jan 23, 2023 | 87.13 | 0.28 | 0.32% | 86.85 | 87.38 | 86.51 |
Jan 20, 2023 | 86.93 | -0.41 | -0.47% | 87.34 | 87.41 | 86.69 |
Jan 19, 2023 | 87.40 | 0.27 | 0.31% | 87.13 | 88.22 | 86.94 |
Jan 18, 2023 | 88.09 | -1.36 | -1.52% | 89.45 | 89.64 | 87.96 |
Jan 17, 2023 | 89.26 | -0.74 | -0.82% | 90.00 | 90.43 | 89.03 |
Jan 13, 2023 | 89.83 | 1.20 | 1.35% | 88.63 | 90.33 | 88.45 |
Jan 12, 2023 | 89.11 | -0.55 | -0.61% | 89.66 | 89.90 | 88.94 |
Jan 11, 2023 | 89.71 | -1.87 | -2.04% | 91.58 | 91.58 | 89.29 |
Jan 10, 2023 | 90.56 | 0.31 | 0.34% | 90.25 | 91.29 | 88.40 |
CVS Health Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
Revenue | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
Cost of Revenue, Total | 146533 | 153448 | 156447 | 158719 | 163981 | 175803 |
Gross Profit | 31013 | 31338 | 38132 | 98057 | 104725 | 116308 |
Total Operating Expense | 167803 | 175248 | 190558 | 244868 | 256235 | 279370 |
Selling/General/Admin. Expenses, Total | 18448 | 18809 | 21368 | 396 | 461 | 523 |
Unusual Expense (Income) | 643 | 181 | 6149 | 559 | 1503 | 2373 |
Other Operating Expenses, Total | 2179 | 2810 | 6594 | 85194 | 90290 | 100671 |
Operating Income | 9743 | 9538 | 4021 | 11908 | 12471 | 12741 |
Interest Income (Expense), Net Non-Operating | -1078 | -1062 | -2619 | -3035 | -2907 | -2503 |
Other, Net | -28 | -208 | 4 | 124 | 206 | 182 |
Net Income Before Taxes | 8637 | 8268 | 1406 | 8997 | 9770 | 10420 |
Net Income After Taxes | 5320 | 5131 | -696 | 6631 | 7201 | 7898 |
Minority Interest | -2 | -1 | 2 | 3 | -13 | 12 |
Net Income Before Extra. Items | 5318 | 5130 | -694 | 6634 | 7188 | 7910 |
Total Extraordinary Items | -1 | 1492 | 100 | 0 | -9 | 0 |
Net Income | 5317 | 6622 | -594 | 6634 | 7179 | 7910 |
Total Adjustments to Net Income | -26 | -16 | -3 | 0 | 0 | |
Income Available to Common Excl. Extra. Items | 5292 | 5114 | -697 | 6634 | 7188 | 7910 |
Income Available to Common Incl. Extra. Items | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
Diluted Net Income | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
Diluted Weighted Average Shares | 1079 | 1024 | 1044 | 1305 | 1314 | 1329 |
Diluted EPS Excluding Extraordinary Items | 4.90454 | 4.99414 | -0.66762 | 5.08352 | 5.47032 | 5.95184 |
Dividends per Share - Common Stock Primary Issue | 1.7 | 2 | 2 | 2 | 2 | 2 |
Diluted Normalized EPS | 5.2716 | 5.10383 | 3.16078 | 5.51501 | 6.31339 | 7.27044 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 69097 | 72616 | 73794 | 76604 | 76826 |
Revenue | 69097 | 72616 | 73794 | 76604 | 76826 |
Cost of Revenue, Total | 40894 | 43520 | 45011 | 46378 | 45509 |
Gross Profit | 28203 | 29096 | 28783 | 30226 | 31317 |
Total Operating Expense | 65520 | 68290 | 71096 | 74464 | 73336 |
Selling/General/Admin. Expenses, Total | 8881 | 8829 | 9190 | ||
Unusual Expense (Income) | 41 | 40 | 814 | 1478 | 525 |
Other Operating Expenses, Total | 15704 | 15901 | 16081 | 26608 | 27302 |
Operating Income | 3577 | 4326 | 2698 | 2140 | 3490 |
Interest Income (Expense), Net Non-Operating | -657 | -636 | -602 | -608 | -586 |
Other, Net | 50 | 45 | 49 | 38 | 42 |
Net Income Before Taxes | 2970 | 3735 | 2145 | 1570 | 2946 |
Net Income After Taxes | 2224 | 2791 | 1587 | 1296 | 2313 |
Minority Interest | -1 | -8 | 11 | 10 | -1 |
Net Income Before Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Net Income | 2223 | 2783 | 1598 | 1306 | 2312 |
Income Available to Common Excl. Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Income Available to Common Incl. Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Diluted Net Income | 2223 | 2783 | 1598 | 1306 | 2312 |
Diluted Weighted Average Shares | 1322 | 1327 | 1329 | 1338 | 1328 |
Diluted EPS Excluding Extraordinary Items | 1.68154 | 2.09721 | 1.20241 | 0.97608 | 1.74096 |
Dividends per Share - Common Stock Primary Issue | 0.5 | 0.5 | 0.5 | 0.5 | 0.55 |
Diluted Normalized EPS | 1.70477 | 2.08539 | 1.65557 | 1.88793 | 2.05135 |
Total Extraordinary Items | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 31042 | 31229 | 45243 | 50302 | 56369 | 60008 |
Cash and Short Term Investments | 3458 | 1807 | 6581 | 8056 | 10854 | 12525 |
Cash & Equivalents | 3371 | 1696 | 4059 | 5683 | 7854 | 9408 |
Short Term Investments | 87 | 111 | 2522 | 2373 | 3000 | 3117 |
Total Receivables, Net | 12164 | 13181 | 17631 | 19617 | 21742 | 24431 |
Accounts Receivable - Trade, Net | 12164 | 13181 | 17631 | 17236 | 7101 | 7932 |
Total Inventory | 14760 | 15296 | 16450 | 17516 | 18496 | 17760 |
Other Current Assets, Total | 660 | 945 | 4581 | 5113 | 5277 | 5292 |
Total Assets | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
Property/Plant/Equipment, Total - Net | 10175 | 10292 | 11349 | 32904 | 33335 | 32018 |
Property/Plant/Equipment, Total - Gross | 22802 | 24290 | 26869 | 49794 | 52035 | 52672 |
Accumulated Depreciation, Total | -12627 | -13998 | -15520 | -16890 | -18700 | -20654 |
Goodwill, Net | 38249 | 38451 | 78678 | 79749 | 79552 | 79121 |
Intangibles, Net | 13511 | 13630 | 36524 | 33121 | 31142 | 29026 |
Other Long Term Assets, Total | 1485 | 1529 | 8930 | 9059 | 9505 | 9801 |
Total Current Liabilities | 26250 | 30648 | 44009 | 53303 | 62017 | 67807 |
Accounts Payable | 17397 | 19218 | 26437 | 30972 | 34869 | 38682 |
Accrued Expenses | 6937 | 6609 | 10711 | 13656 | 15810 | 19229 |
Notes Payable/Short Term Debt | 1874 | 1276 | 720 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 42 | 3545 | 1265 | 3781 | 5440 | 4205 |
Total Liabilities | 57632 | 57440 | 138231 | 158585 | 161326 | 157924 |
Total Long Term Debt | 25615 | 22181 | 71444 | 64699 | 59207 | 51971 |
Long Term Debt | 25615 | 22181 | 71444 | 63918 | 58157 | 50721 |
Deferred Income Tax | 4214 | 2996 | 7677 | 7294 | 6794 | 6270 |
Minority Interest | 4 | 4 | 318 | 306 | 312 | 306 |
Other Liabilities, Total | 1549 | 1611 | 14783 | 32983 | 32996 | 31570 |
Total Equity | 36830 | 37691 | 58225 | 63864 | 69389 | 75075 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 17 | 17 | 45440 | 45972 | 46513 | 47377 |
Additional Paid-In Capital | 31618 | 32079 | ||||
Retained Earnings (Accumulated Deficit) | 38983 | 43556 | 40911 | 45108 | 49640 | 54906 |
Treasury Stock - Common | -33483 | -37796 | -28228 | -28235 | -28178 | -28173 |
Other Equity, Total | -305 | -165 | 5 | 245 | 200 | 187 |
Total Liabilities & Shareholders’ Equity | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
Total Common Shares Outstanding | 1061 | 1014 | 1295 | 1302 | 1310 | 1322 |
Long Term Investments | 15732 | 17314 | 20812 | 23025 | ||
Other Current Liabilities, Total | 4876 | 4894 | 5898 | 5691 | ||
Unrealized Gain (Loss) | 97 | 774 | 1214 | 778 | ||
Capital Lease Obligations | 781 | 1050 | 1250 | |||
Total Preferred Shares Outstanding | 0 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 55719 | 56559 | 60842 | 60008 | 61483 |
Cash and Short Term Investments | 8788 | 10125 | 12841 | 12525 | 11342 |
Cash & Equivalents | 5598 | 7119 | 9826 | 9408 | 8442 |
Short Term Investments | 3190 | 3006 | 3015 | 3117 | 2900 |
Total Receivables, Net | 23855 | 24164 | 25283 | 24431 | 26451 |
Accounts Receivable - Trade, Net | 18304 | 18976 | 8398 | 7932 | 8728 |
Total Inventory | 17618 | 16979 | 17399 | 17760 | 18160 |
Other Current Assets, Total | 5458 | 5291 | 5319 | 5292 | 5530 |
Total Assets | 229606 | 231164 | 234891 | 232999 | 232873 |
Property/Plant/Equipment, Total - Net | 33153 | 33140 | 33233 | 32018 | 31645 |
Goodwill, Net | 79552 | 79552 | 79121 | 79121 | 79060 |
Intangibles, Net | 30639 | 30080 | 29545 | 29026 | 28543 |
Long Term Investments | 21025 | 22136 | 22370 | 23025 | 22595 |
Other Long Term Assets, Total | 9518 | 9697 | 9780 | 9801 | 9547 |
Total Current Liabilities | 60104 | 59311 | 64709 | 67807 | 69780 |
Accounts Payable | 35358 | 36691 | 39468 | 38682 | 41570 |
Accrued Expenses | 16018 | 16539 | 17871 | 19229 | 18388 |
Notes Payable/Short Term Debt | 252 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2422 | 60 | 1561 | 4205 | 4217 |
Other Current Liabilities, Total | 6054 | 6021 | 5809 | 5691 | 5605 |
Total Liabilities | 158756 | 157920 | 160583 | 157924 | 159043 |
Total Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
Deferred Income Tax | 6610 | 6557 | 6329 | 6270 | 5829 |
Minority Interest | 314 | 321 | 310 | 306 | 310 |
Other Liabilities, Total | 32458 | 32437 | 32403 | 31570 | 31061 |
Total Equity | 70850 | 73244 | 74308 | 75075 | 73830 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 46727 | 46995 | 47133 | 47377 | 47677 |
Retained Earnings (Accumulated Deficit) | 51203 | 53331 | 54264 | 54906 | 56488 |
Treasury Stock - Common | -28102 | -28252 | -28166 | -28173 | -30145 |
Unrealized Gain (Loss) | 828 | 977 | 904 | 778 | -377 |
Other Equity, Total | 194 | 193 | 173 | 187 | 187 |
Total Liabilities & Shareholders’ Equity | 229606 | 231164 | 234891 | 232999 | 232873 |
Total Common Shares Outstanding | 1313 | 1318 | 1321 | 1322 | 1306 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash From Operating Activities | 10141 | 8007 | 8865 | 12848 | 15865 | 18265 |
Cash Receipts | 172310 | 176594 | 186519 | 248393 | 264327 | 284219 |
Cash Payments | -142511 | -146469 | -148821 | -149655 | -158636 | -165783 |
Cash Taxes Paid | -3060 | -2909 | -2383 | -2717 | -2929 | -3195 |
Cash Interest Paid | -1140 | -1072 | -2803 | -2954 | -2904 | -2469 |
Changes in Working Capital | -15458 | -18137 | -23647 | -80219 | -83993 | -94507 |
Cash From Investing Activities | -2470 | -2877 | -43285 | -3339 | -5534 | -5261 |
Capital Expenditures | -2224 | -1918 | -2037 | -2457 | -2437 | -2520 |
Other Investing Cash Flow Items, Total | -246 | -959 | -41248 | -882 | -3097 | -2741 |
Cash From Financing Activities | -6761 | -6751 | 36819 | -7654 | -7696 | -11356 |
Financing Cash Flow Items | -142 | -72 | 350 | 59 | 337 | -13 |
Total Cash Dividends Paid | -1840 | -2049 | -2038 | -2603 | -2624 | -2625 |
Issuance (Retirement) of Stock, Net | -4165 | -4032 | 242 | 210 | 264 | 549 |
Issuance (Retirement) of Debt, Net | -614 | -598 | 38265 | -5320 | -5673 | -9267 |
Foreign Exchange Effects | 2 | 1 | -4 | |||
Net Change in Cash | 912 | -1620 | 2395 | 1855 | 2635 | 1648 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Cash From Operating Activities | 2892 | 8739 | 14260 | 18265 | 3563 |
Cash Receipts | 66487 | 136621 | 209104 | 284219 | 74192 |
Cash Payments | -39171 | -79316 | -122129 | -165783 | -44365 |
Cash Taxes Paid | -44 | -1552 | -2397 | -3195 | -96 |
Cash Interest Paid | -876 | -1263 | -2095 | -2469 | -782 |
Changes in Working Capital | -23504 | -45751 | -68223 | -94507 | -25386 |
Cash From Investing Activities | -1867 | -2974 | -3821 | -5261 | -1993 |
Capital Expenditures | -829 | -1315 | -1923 | -2520 | -1082 |
Other Investing Cash Flow Items, Total | -1038 | -1659 | -1898 | -2741 | -911 |
Cash From Financing Activities | -3185 | -6558 | -8525 | -11356 | -2650 |
Financing Cash Flow Items | 56 | -159 | -164 | -13 | -211 |
Total Cash Dividends Paid | -656 | -1306 | -1965 | -2625 | -722 |
Issuance (Retirement) of Stock, Net | 212 | 330 | 440 | 549 | -1703 |
Issuance (Retirement) of Debt, Net | -2797 | -5423 | -6836 | -9267 | -14 |
Net Change in Cash | -2160 | -793 | 1914 | 1648 | -1080 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7762 | 115316851 | 1721829 | 2022-09-30 | LOW |
Capital World Investors | Investment Advisor | 4.6346 | 60896763 | 2060715 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.586 | 60258711 | 234645 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4403 | 58344728 | -339582 | 2022-09-30 | LOW |
Capital International Investors | Investment Advisor | 1.9717 | 25907490 | -351533 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7789 | 23374421 | 186288 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 1.6592 | 21801147 | 696280 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.5392 | 20224681 | 368634 | 2022-09-30 | LOW |
BofA Global Research (US) | Research Firm | 1.1617 | 15264714 | 80812 | 2022-09-30 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 1.0254 | 13472772 | -236945 | 2022-09-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.9993 | 13129851 | -500609 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9936 | 13055500 | -67996 | 2021-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.9056 | 11899729 | 224538 | 2022-09-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7675 | 10085134 | -130262 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7495 | 9847659 | -473501 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.726 | 9539067 | -771778 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.7187 | 9443400 | -8279 | 2022-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6884 | 9045542 | -197163 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.673 | 8843195 | -63183 | 2022-09-30 | LOW |
Nordea Funds Oy | Investment Advisor | 0.6619 | 8697324 | -983166 | 2022-09-30 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group +500000+
Trader
93000+
Klien aktif per bulan
$57000000+
Volume investasi per bulan
$31000000+
Coba sekarang Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Healthcare Facilities & Services (NEC) |
1 Cvs Dr
WOONSOCKET
RHODE ISLAND 02895-6146
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com